Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
sitagliptin (januvia) (1 trial)
ketamine (ketalar) (1 trial)
Autism Spectrum Disorder (Phase 4)
Bipolar Disorder (Phase 4)
Depression (Phase 1)
Disease (Phase 4)
Psychotic Disorders (Phase 4)
Schizophrenia (Phase 4)
Trials (2 total)
Trial APIs (2 total)